Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparation

International Archives of Allergy and Immunology

Volumn 160, Issue 4, 2013, Pages 420-424

  Pfaar, Oliver ^a   Van Twuijver, Esther ^c   Hecker, Heike ^b   Boot, Johan Diderik ^c   Van Ree, Ronald ^d   Klimek, Ludger ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Medical Department HAL Allergie GmbH   (Germany)

^c HAL Allergy BV   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

(Allergen )specific subcutaneous immunotherapy; Allergic rhinitis; Cluster specific immunotherapy; Rush specific immunotherapy; Safety

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; POLLEN ANTIGEN; PURETHAL; UNCLASSIFIED DRUG; GRASS POLLEN EXTRACT;

ADULT; AGED; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; GERMANY; GRASS POLLEN; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTENTION TO TREAT ANALYSIS; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE PROVOCATION TEST; OPEN STUDY; PARALLEL DESIGN; PHASE 4 CLINICAL TRIAL; PHYSICAL EXAMINATION; POLLEN ALLERGY; PRICK TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SUBCUTANEOUS IMMUNOTHERAPY; SYSTEMIC DISEASE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; ALLERGOID GRASS POLLEN; DRUG DOSE COMPARISON; DRUG TOLERABILITY; MAINTENANCE THERAPY;

ADOLESCENT; ADULT; AGED; ALLERGENS; ANTIGENS, PLANT; ASTHMA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULIN G; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PLANT EXTRACTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; YOUNG ADULT;

EID: 84869868838     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000343026     Document Type: Article

References (16)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update [in collaboration with the World Health Organization, GA(2)LEN and Aller- Gen]. Allergy 2008; 63(suppl 86):8-160.
2. Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham S: Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 2007; CD001936.
3. Bousquet J, Michel FB: Safety considerations in assessing the role of immunotherapy in allergic disorders. Drug Saf 1994; 10: 5-17.
4. Grammer LC, Shaughnessy MA, Patterson R: Modified forms of allergen immunotherapy. J Allergy Clin Immunol 1985; 76: 397-401.
5. Alvarez-Cuesta E, Bousquet J, Canonica GW, Durham SR, Malling HJ, Valovirta E: Standards for practical allergen-specific immunotherapy. Allergy 2006; 61(suppl 82):1-20.
6. Hansen I, Hormann K, Stuck BA, Schneider- Gene S, Mosges R, Klimek L: Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal) (in German). Laryngorhinootologie 2003; 82: 558-563.
7. Penas A, Bosque M, Cruz M, Garcia M: Observational study of the safety of an accelerated subcutaneous immuntherapy regimen in a pediatric population. Allergy 2011; 66(suppl 94):207.
8. Pfaar O, Klimek L, Fischer I, Sieber J, Amoroso S, Moreno AC et al: Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens. Int Arch Allergy Immunol 2009; 150: 102-108.
9. Pfaar O, Leitzbach S, Hormann K, Klimek L: Cluster protocols in SCIT: enough evidence for practical use? Curr Opin Allergy Clin Immunol 2010; 10: 188-193.
10. Subiza J, Feliu A, Subiza JL, Uhlig J, Fernandez- Caldas E: Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment. Clin Exp Allergy 2008; 38: 987-994.
11. Tabar AI, Echechipia S, Garcia BE, Olaguibel JM, Lizaso MT, Gomez B et al: Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol 2005; 116: 109-118.
12. Zhang L, Wang C, Han D, Wang X, Zhao Y, Liu J: Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis. Int Arch Allergy Immunol 2009; 148: 161-169.
13. Ariano R, Canonica GW, Passalacqua G: Possible role of climate changes in variations in pollen seasons and allergic sensitizations during 27 years. Ann Allergy Asthma Immunol 2010; 104: 215-222.
14. de Weger LA, Hiemstra PS: The effect of climate change on pollen allergy in the Netherlands (in Dutch). Ned Tijdschr Geneeskd 2009; 153:A1410.
15. Schubert R, Eickmeier O, Garn H, Baer PC, Mueller T, Schulze J, et al: Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy. Int Arch Allergy Immunol 2009; 148: 251-260.
16. Mellerup MT, Hahn GW, Poulsen LK, Malling H: Safety of allergen-specific immunotherapy: relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment. Clin Exp Allergy 2000; 30: 1423-1429.